Arthur Y Hung

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. ncbi Radiation therapy for gastrointestinal cancer
    Arthur Y Hung
    Department of Radiation Oncology, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Hematol Oncol Clin North Am 20:287-320. 2006
  2. ncbi Minimal benefit of an endorectal balloon for prostate immobilization as verified by daily localization
    Arthur Y Hung
    Department of Radiation Oncology, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Med Dosim 36:195-9. 2011
  3. ncbi Contemporary management of high-risk localized prostate cancer
    Mark Garzotto
    Division of Urology, Department of Surgery, and the Department of Radiation Medicine, Oregon Health and Science University, Portland Veterans Administration Medical Center, Portland, OR, 97239, USA
    Curr Urol Rep 11:159-64. 2010
  4. ncbi Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion
    James A Tanyi
    Department of Radiation Medicine, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Int J Radiat Oncol Biol Phys 78:1579-85. 2010
  5. ncbi Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas
    Christopher W Ryan
    Department of Medicine, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR 97239, USA
    Cancer 112:2432-9. 2008
  6. ncbi Technological advances in radiation therapy for prostate cancer
    Mehee Choi
    Department of Radiation Medicine, KPV4, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239 3098, USA
    Curr Urol Rep 11:172-9. 2010
  7. ncbi Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis
    Arthur Y Hung
    Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer J 8:440-4. 2002

Detail Information

Publications7

  1. ncbi Radiation therapy for gastrointestinal cancer
    Arthur Y Hung
    Department of Radiation Oncology, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Hematol Oncol Clin North Am 20:287-320. 2006
    ..Further scientific investigation is needed to establish the optimal role of radiation and to better define its integration with novel systemic and biologic modalities...
  2. ncbi Minimal benefit of an endorectal balloon for prostate immobilization as verified by daily localization
    Arthur Y Hung
    Department of Radiation Oncology, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Med Dosim 36:195-9. 2011
    ..Day-to-day variability of the position of the prostate is reduced in all dimensions with the water-filled ERB, but not significantly statistically. Use of the water-filled ERB did not obviate performing some form of image guidance daily...
  3. ncbi Contemporary management of high-risk localized prostate cancer
    Mark Garzotto
    Division of Urology, Department of Surgery, and the Department of Radiation Medicine, Oregon Health and Science University, Portland Veterans Administration Medical Center, Portland, OR, 97239, USA
    Curr Urol Rep 11:159-64. 2010
    ..It is likely that the development of effective strategies based on understanding prostate tumor biology will lead to significant advances in the treatment of this disease...
  4. ncbi Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion
    James A Tanyi
    Department of Radiation Medicine, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Int J Radiat Oncol Biol Phys 78:1579-85. 2010
    ....
  5. ncbi Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas
    Christopher W Ryan
    Department of Medicine, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR 97239, USA
    Cancer 112:2432-9. 2008
    ..The authors studied a dose-intense regimen of epirubicin and ifosfamide with hypofractionated preoperative radiotherapy for high-risk soft tissue sarcomas. The primary objective was estimation of the rate of >or=95% pathologic necrosis...
  6. ncbi Technological advances in radiation therapy for prostate cancer
    Mehee Choi
    Department of Radiation Medicine, KPV4, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239 3098, USA
    Curr Urol Rep 11:172-9. 2010
    ..This review summarizes the recent technical advances made in radiation dose delivery, including target volume definition, treatment planning, treatment delivery methods, and positional verification methods during RT...
  7. ncbi Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis
    Arthur Y Hung
    Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer J 8:440-4. 2002
    ..Improvement in prostate imaging and multiple core biopsies may be helpful in better defining the extent of disease in the individual patient...